Quantity size:
0.2ml
Concentration:
1mg/ml 结蛋白抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
filaments found in muscle cells. In adult striated muscle they form a fibrous network connecting myofibrils to each other and to the plasma membrane from the periphery of the Z line structures. Defects in Desmin are the cause of desmin related cardio skeletal myopathy (CSM) 结蛋白抗体also known as desmin related myopathy (DRM). CSM is characterized by skeletal muscle weakness associated with cardiac conduction blocks, arrhythmias, restrictive heart failure, and by intracytoplasmic accumulation of desmin reactive deposits in cardiac and skeletal muscle cells. A desmin related myopathy can have a distal onset, it is then known as hereditary distal myopathy (HDM). Defects in Desmin are also the cause of dilated cardiomyopathy type 1I 结蛋白抗体(CMD1I). CMD1I is an autosomal form of dilated cardiomyopathy characterized by ventricular dilatation and impaired systolic function. Antidesmin antibodies are useful in identification of tumours of myogenic origin.
Also known as:
结蛋白抗体CMD1I; CSM1; CSM2; DES; FLJ12025; FLJ39719; FLJ41013; FLJ41793; Intermediate filament protein; OTTHUMP00000064865; DESM_HUMAN; Desmin; FLJ12025; FLJ39719; FLJ41013; FLJ41793.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep, Guinea Pig, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Desmin.
●
Predicted Molecular Weight: 52kDa.
Storage:
结蛋白抗体Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl611Hu01血小板反应蛋白(THBS1)多克隆抗体Polyclonal Antibody to Thrombospondin 1 (THBS1)
kl611Mu01血小板反应蛋白(THBS1)多克隆抗体Polyclonal Antibody to Thrombospondin 1 (THBS1)
kl611Ra01血小板反应蛋白(THBS1)多克隆抗体Polyclonal Antibody to Thrombospondin 1 (THBS1)
kl613Hu01谷胱甘肽S转移酶θ2(GSTθ2)多克隆抗体Polyclonal Antibody to Glutathione S Transferase Theta 2 (GSTt2)
kl613Mu01谷胱甘肽S转移酶θ2(GSTθ2)多克隆抗体Polyclonal Antibody to Glutathione S Transferase Theta 2 (GSTt2)
kl613Ra01谷胱甘肽S转移酶θ2(GSTθ2)多克隆抗体Polyclonal Antibody to Glutathione S Transferase Theta 2 (GSTt2)
kl615Hu01纤溶抑制因子(TAFI)多克隆抗体Polyclonal Antibody to Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
kl615Mu01纤溶抑制因子(TAFI)多克隆抗体Polyclonal Antibody to Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
kl615Ra01纤溶抑制因子(TAFI)多克隆抗体Polyclonal Antibody to Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
kl616Hu01V-Rel网状内皮增生病毒癌基因同源物A(RELA)多克隆抗体Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl616Mu01V-Rel网状内皮增生病毒癌基因同源物A(RELA)多克隆抗体Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl616Ra01V-Rel网状内皮增生病毒癌基因同源物A(RELA)多克隆抗体Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl618Hu01速激肽受体2(TACR2)多克隆抗体Polyclonal Antibody to Tachykinin Receptor 2 (TACR2)
kl618Mu01速激肽受体2(TACR2)多克隆抗体Polyclonal Antibody to Tachykinin Receptor 2 (TACR2)
kl618Ra01速激肽受体2(TACR2)多克隆抗体Polyclonal Antibody to Tachykinin Receptor 2 (TACR2)
kl620Hu01解整合素金属蛋白酶8(ADAM8)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 8 (ADAM8)
kl620Mu01解整合素金属蛋白酶8(ADAM8)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 8 (ADAM8)
kl620Ra01解整合素金属蛋白酶8(ADAM8)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 8 (ADAM8)
kl622Hu01谷胱甘肽S转移酶θ1(GSTθ1)多克隆抗体Polyclonal Antibody to Glutathione S Transferase Theta 1 (GSTt1)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话